Neurocrine Biosciences
Stock Forecast, Prediction & Price Target
Neurocrine Biosciences Financial Estimates
Neurocrine Biosciences Revenue Estimates
Neurocrine Biosciences EBITDA Estimates
Neurocrine Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $1.13B N/A | $1.48B 31.33% | $1.88B 26.76% | Avg: $2.61B Low: $2.61B High: $2.61B avg. 38.70% | Avg: $2.97B Low: $2.97B High: $2.97B avg. 13.56% | Avg: $3.34B Low: $3.34B High: $3.34B avg. 12.59% | Avg: $3.80B Low: $3.80B High: $3.80B avg. 13.61% |
Net Income
% change YoY
| $89.6M N/A | $154.5M 72.43% | $249.7M 61.61% | Avg: $705.22M Low: $705.22M High: $705.22M avg. 182.43% | Avg: $895.67M Low: $895.67M High: $895.67M avg. 27.00% | Avg: $1.06B Low: $1.06B High: $1.06B avg. 19.43% | Avg: $1.31B Low: $1.31B High: $1.31B avg. 22.75% |
EBITDA
% change YoY
| $207.8M N/A | $249M 19.82% | $358M 43.77% | Avg: $613.39M Low: $613.39M High: $613.39M avg. 71.33% | Avg: $696.62M Low: $696.62M High: $696.62M avg. 13.56% | Avg: $784.38M Low: $784.38M High: $784.38M avg. 12.59% | Avg: $891.21M Low: $891.21M High: $891.21M avg. 13.61% |
EPS
% change YoY
| $0.95 N/A | $1.61 69.47% | $2.56 59.00% | Avg: $6.98 Low: $6.98 High: $6.98 avg. 172.75% | Avg: $8.87 Low: $8.87 High: $8.87 avg. 27.00% | Avg: $10.59 Low: $10.59 High: $10.59 avg. 19.43% | Avg: $13 Low: $13 High: $13 avg. 22.75% |
Operating Expenses
% change YoY
| $911.4M N/A | $1.21B 33.47% | $1.59B 31.23% | Avg: $1.23B Low: $1.23B High: $1.23B avg. -22.80% | Avg: $1.39B Low: $1.39B High: $1.39B avg. 13.56% | Avg: $1.57B Low: $1.57B High: $1.57B avg. 12.59% | Avg: $1.79B Low: $1.79B High: $1.79B avg. 13.61% |
FAQ
What is Neurocrine Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 62.90% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is 705.22M, average is 705.22M and high is 705.22M.
What is Neurocrine Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 19.62% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $2.61B, average is $2.61B and high is $2.61B.
What is Neurocrine Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 60.48% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is $6.98, average is $6.98 and high is $6.98.